291 related articles for article (PubMed ID: 30572494)
1. Efficacy of mineralocorticoid receptor antagonists in postmyocardial infarction patients with or without left ventricular dysfunction: A meta-analysis of randomized controlled trials.
Xu Y; Qiu Z; Yang R; Wu Y; Cheng X
Medicine (Baltimore); 2018 Dec; 97(51):e13690. PubMed ID: 30572494
[TBL] [Abstract][Full Text] [Related]
2. Effects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials.
Chen Y; Wang H; Lu Y; Huang X; Liao Y; Bin J
BMC Med; 2015 Jan; 13():10. PubMed ID: 25598008
[TBL] [Abstract][Full Text] [Related]
3. Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials.
Rossello X; Ariti C; Pocock SJ; Ferreira JP; Girerd N; McMurray JJV; Van Veldhuisen DJ; Pitt B; Zannad F
Clin Res Cardiol; 2019 May; 108(5):477-486. PubMed ID: 30264282
[TBL] [Abstract][Full Text] [Related]
4. Impact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Le HH; El-Khatib C; Mombled M; Guitarian F; Al-Gobari M; Fall M; Janiaud P; Marchant I; Cucherat M; Bejan-Angoulvant T; Gueyffier F
PLoS One; 2016; 11(2):e0145958. PubMed ID: 26891235
[TBL] [Abstract][Full Text] [Related]
5. Effects of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with left ventricular systolic dysfunction: a meta-analysis of randomized controlled trials.
Bapoje SR; Bahia A; Hokanson JE; Peterson PN; Heidenreich PA; Lindenfeld J; Allen LA; Masoudi FA
Circ Heart Fail; 2013 Mar; 6(2):166-73. PubMed ID: 23403436
[TBL] [Abstract][Full Text] [Related]
6. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.
Butler J; Ezekowitz JA; Collins SP; Givertz MM; Teerlink JR; Walsh MN; Albert NM; Westlake Canary CA; Carson PE; Colvin-Adams M; Fang JC; Hernandez AF; Hershberger RE; Katz SD; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Stough WG; Starling RC
J Card Fail; 2012 Apr; 18(4):265-81. PubMed ID: 22464767
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials.
Ezekowitz JA; McAlister FA
Eur Heart J; 2009 Feb; 30(4):469-77. PubMed ID: 19066207
[TBL] [Abstract][Full Text] [Related]
8. Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis.
Berbenetz NM; Mrkobrada M
BMC Cardiovasc Disord; 2016 Dec; 16(1):246. PubMed ID: 27905877
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: a systematic review and network meta-analysis of 32 randomized trials.
Pamporis K; Karakasis P; Sagris M; Zarifis I; Bougioukas KI; Pagkalidou E; Milaras N; Samaras A; Theofilis P; Fragakis N; Tousoulis D; Xanthos T; Giannakoulas G
Curr Probl Cardiol; 2024 Jul; 49(7):102615. PubMed ID: 38692445
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction.
Lax A; Sanchez-Mas J; Asensio-Lopez MC; Fernandez-Del Palacio MJ; Caballero L; Garrido IP; Pastor-Perez FJ; Januzzi JL; Pascual-Figal DA
JACC Heart Fail; 2015 Jan; 3(1):50-58. PubMed ID: 25458175
[TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoid receptor antagonists in patients with acute myocardial infarction - A systematic review and meta-analysis of randomized trials.
Bossard M; Binbraik Y; Beygui F; Pitt B; Zannad F; Montalescot G; Jolly SS
Am Heart J; 2018 Jan; 195():60-69. PubMed ID: 29224647
[TBL] [Abstract][Full Text] [Related]
12. Early Aldosterone Blockade in Acute Myocardial Infarction: The ALBATROSS Randomized Clinical Trial.
Beygui F; Cayla G; Roule V; Roubille F; Delarche N; Silvain J; Van Belle E; Belle L; Galinier M; Motreff P; Cornillet L; Collet JP; Furber A; Goldstein P; Ecollan P; Legallois D; Lebon A; Rousseau H; Machecourt J; Zannad F; Vicaut E; Montalescot G;
J Am Coll Cardiol; 2016 Apr; 67(16):1917-27. PubMed ID: 27102506
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
Kang S; Yang Y; Li CJ; Gao R
Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
[TBL] [Abstract][Full Text] [Related]
14. Retrospective review of in hospital use of mineralocorticoid receptor antagonists for high risk patients following myocardial infarction.
Miller RJ; Howlett JG
BMC Cardiovasc Disord; 2015 Jun; 15():46. PubMed ID: 26060129
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
16. Effects of mineralocorticoid receptor antagonists on left ventricular mass in chronic kidney disease patients: a systematic review and meta-analysis.
Lu R; Zhang Y; Zhu X; Fan Z; Zhu S; Cui M; Zhang Y; Tang F
Int Urol Nephrol; 2016 Sep; 48(9):1499-509. PubMed ID: 27193436
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a network meta-analysis of randomized controlled trials.
Yang P; Shen W; Chen X; Zhu D; Xu X; Wu T; Xu G; Wu Q
Heart Fail Rev; 2019 Sep; 24(5):637-646. PubMed ID: 31030322
[TBL] [Abstract][Full Text] [Related]
18. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
Pitt B; Remme W; Zannad F; Neaton J; Martinez F; Roniker B; Bittman R; Hurley S; Kleiman J; Gatlin M;
N Engl J Med; 2003 Apr; 348(14):1309-21. PubMed ID: 12668699
[TBL] [Abstract][Full Text] [Related]
19. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
Peck KY; Lim YZ; Hopper I; Krum H
Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis.
Liu T; Korantzopoulos P; Shao Q; Zhang Z; Letsas KP; Li G
Europace; 2016 May; 18(5):672-8. PubMed ID: 26705563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
